Clinical Trial Update: Rosiglitazone Versus Placebo in Chronic Stable Angina [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing rosiglitazone to placebo in chronic stable angina was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Metabolic Syndrome

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: University of Glasgow | Conditions: Angina Pectoris, Metabolic Syndrome X | Phase 4 | Status: TERMINATED